A curated listing of global health funding opportunities.
About
At the General Assembly, hosted by WHO in Geneva 3 to 4 December, the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) coalition of research funders launched a new funding mechanism, "Global Research Improving Pandemic Preparedness (GRIPP)". This initiative aims to improve collaboration between international research funders around the world, improving our research responses to future outbreaks, epidemics and wider health emergencies.
The first GRIPP call, focused on strengthening the clinical research ecosystem in LMICs to improve clinical trial good practices aligned with WHO guidance and GloPID-R Roadmap for Clinical Trial Coordination, will be launched in early 2025.
About
Notices of funding opportunities (NOFO) for HIV and TB work in Lesotho, the Dominican Republic, Malawi, Ukraine, Zambia, Central America and the Kingdom of Eswatini.
- Sustaining HIV and TB epidemic control in Lesotho through health system strengthening and technical assistance under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 Feb 2025
- Advancing country-led sustainable digital health transformation across PEPFAR-supported countries through informatics workforce capacity development to end HIV/AIDS and TB as a public health threat by 2030 under PEPFAR. Closing date: 21 Feb 2025
- Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 21 Feb 2025
- Improving quality of care and health outcomes through innovative systems and technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 21 Feb 2025
- Sustaining HIV services for key and priority populations through enhanced differentiated testing, innovative treatment and prevention approaches, and continuous support to Ukraine Ministry of Health, Public Health Center, and communities under PEPFAR. Closing date: 21 Feb 2025
- Providing targeted technical assistance to the HIV/TB prevention-care-treatment continuum using cost efficient and scalable quality improvement approaches to address program gaps in support of sustainable HIV services in Zambia under PEPFAR. Closing date: 24 Feb 2025
- Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 24 February 2025
About
Notices of funding opportunities (NOFO) for global health and health care systems work in Kenya, Namibia, South Africa, Botswana, Zimbabwe, Malawi, Uganda, India, Botswana, Sierra Leone, Tanzania and Caribbean countries.
- Innovative Approaches for TB Prevention and Case Finding to END TB. Closing date: 3 March 2025
- Supporting sustainable, accessible, integrated and quality laboratory systems for HIV/TB and related health threats in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025
- Strengthening the Government of Namibia’s health information systems (HIS) to improve public health programs under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025
- Strengthening economic analysis and capacity in support of program management for HIV, TB, and related health threats in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR). Closing date: 20 February 2025
- Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the PEPFAR. Closing date: 20 February 2025
- Strengthening the Botswana Ministry of Health (MOH) laboratory and health systems through technical assistance (TA) to effectively manage and sustain a quality HIV/TB program in Botswana under the PEPFAR. Closing date: 19 February 2025
- Strengthening comprehensive HIV and TB services and health systems in high-burden areas of Namibia under the PEPFAR. Closing date: 19 February 2025
- Provide technical assistance to the Botswana Ministry of Health to implement HIV/TB policies and services for children and adolescents living with HIV including mental health and psychosocial support and pregnant and breastfeeding women under the PEPFAR. Closing date: 19 February 2025
- Provide technical assistance (TA) to support the Botswana Ministry of Health (MOH) implement policies and programs across the HIV clinical and prevention cascade under the PEPFAR. Closing date: 19 February 2025
- Implementation of integrated, resilient, and sustainable health systems for HIV/TB epidemic control in the Republic of Kenya under the PEPFAR. Closing date: 19 February 2025
- Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the PEPFAR. Closing date: 18 February 2025
- Support for laboratory diagnosis and monitoring to scale up and improve HIV/AIDS care and treatment services for Caribbean countries supported under the PEPFAR. Closing date: 18 February 2025
- Strengthening comprehensive HIV prevention interventions in Malawi under the PEPFAR. Closing date: 18 February 2025
- Strengthening civil society organizations' capacity and coordination to accelerate HIV epidemic control in Uganda by implementing comprehensive HIV/AIDS prevention and treatment for key and priority populations under the PEPFAR. Closing date: 18 February 2025
- Strengthening and modernizing sustainable public health systems and workforce in Uganda for data science, informatics, surveys, and surveillance for timely, accurate, and integrated data for action under the PEPFAR. Closing date: 18 February 2025
- Ending HIV as a public health threat by sustaining and accelerating a comprehensive HIV and TB response in India under the PEPFAR. Closing date: 24 February 2025
- Strengthening Botswana's national health data systems for a sustainable and government-led HIV/TB and related public health threat response through enhanced surveillance, digital health, and data analytics under the PEPFAR. Closing date: 24 February 2025
- Strengthening the national HIV care and treatment program in Sierra Leone (SL) to accelerate the response to end the HIV/AIDS pandemic as a public health threat by 2030, under the PEPFAR. Closing date 24 February 2025
- Capacity building and technical assistance for sustainable community-led monitoring (CLM) of HIV services in Sierra Leone (SL) under the PEPFAR. Closing date: 24 February 2025
- Implement and sustain a comprehensive response to HIV and technical assistance to strengthen the capacity of regional authorities in the United Republic of Tanzania under PEPFAR. Closing date: 25 February 2025
- Strengthening India’s integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the PEPFAR. Closing date: 25 February 2025
About
This call offers opportunities for NIHR GHR Academy Members to spend time in other NIHR Global Health Research Programmes or different parts of the NIHR, including overseas partner institutions and industry partners with existing NIHR links. On their GHR SPARC placement, GHR Academy members will get the opportunity to: network, learn a specific skill, collaborate with other researchers/specialists, increase their understanding of NIHR funding and enhance their career development.
ELIGIBILITY
This opportunity is open to NIHR GHR Academy Members. A NIHR GHR Academy Member is someone who is receiving funding from, or being supported by, an NIHR Global Health Research programme to develop their academic career. Your NIHR GHR programme must have a contract end date after 31 December 2025 and you must currently be undertaking a Pre-doctoral fellowship/Masters, PhD or Post-doctoral fellowship or being supported to apply for a formal training/career development award
Amount
Up to £10,000
Deadline
13 February 2024
Apply for NIHR: Global Health Research Short Placement Award for Research Collaboration
ABOUT
This funding call will generate a body of evidence on the health effects of climate change mitigation interventions in low- and middle-income countries (LMICs). This award will fund transdisciplinary research teams, led by an applicant at an LMIC-based institution. Research funded will investigate health effects alongside the social and economic impacts of planned or implemented greenhouse gas mitigation strategies. Research will reflect local priorities and produce evidence to drive positive climate and health outcomes. Webinar 9 December 2024. Preliminary application deadline: 18 February 2025.
AMOUNT
£500,000-£2 million per project for 2 - 4 years
Frequency: One-off
ELIGIBILITY
Lead applicant career stage: Established researcher
Co-applicants: Accepted
Administering organisation location: Low- or middle-income countries (apart from mainland China)
About
This programme gives ODA-eligible early-career to senior researchers the opportunity to work with peers around the world to inform policymaking through quality evidence and research. Only open to proposals related to evidence-informed policy-making in Brazil, Egypt, Indonesia, Jordan, Kenya, Malaysia, Philippines, South Africa, Turkey, Thailand, Vietnam and/or Least Developed Countries. This programme is part of the £337m International Science Partnerships Fund, which is designed to enable potential and foster prosperity.
This programme will support grants in the following areas:
- Research related to how evidence use theory and research has been implemented in practice.
- Research or research-based activities related to knowledge systems strengthening and/or organisational change to support evidence use in practice.
- Knowledge systems strengthening and/or organisational change to support evidence use in practice.
The Academy is looking to support awards that work in the following fields:
- Environment, Sustainability & Nature
- Transformative Technologies
- Health & Wellbeing
- Cities & Urbanisation
- Global Order, Geopolitics and International Affairs
Eligibility
The PI must be of postdoctoral or above status (or have equivalent research experience). The PI must hold an established role in an eligible university or research institute in the UK, Brazil, Egypt, Indonesia, Jordan, Kenya, Malaysia, Philippines, South Africa, Turkey, Thailand, Vietnam and/or Least Developed Countries. Applications for this funding must be ODA-eligible.
Amount
Awards are for a period of 12 months, with a maximum award value of £150,000.
Apply to the British Academy: Evidence informed policymaking grants
About
This call offers opportunities for ODA Global Innovation Fellowship award holders to embed themselves with C40, in their London office, to expand their networks and create new links across policy and academia. C40 is a global network of nearly 100 mayors of the world’s leading cities that are united in action to confront the climate crisis.
The aim is to have a mutually beneficial partnership between the fellowship award holder and C40, with each able to take advantage of fresh perspectives and expand their networks and reach. It will enable the award holder to strengthen and create new links across policy and academia, enabling knowledge mobilisation and translation, and the opportunity to develop new approaches and solutions to policy challenges through providing a different perspective.
Applications must have a contextual focus on places where C40 have city partners and are eligible foci for this call. These are South Africa, Kenya, Sierra Leone, Tanzania, Ethiopia, Thailand, Vietnam, Indonesia, Malaysia, Philippines, Brazil, Jordan, and Bangladesh.
Applications are invited in any of the following areas:
Cities, Climate & Housing
Cities, Climate & Health
ELIGIBILITY
Early-career, Mid-career.
Amount
The Academy is offering up to one to two one-year fellowships hosted in C40,’s office in London. These are offered as awards for up to £120,000 for 12 months in duration (with Full Economic Costing at 80 per cent).
Deadline
19 February 2025
About
The AMR Knowledge Exchange Fund supports early-career researchers and DPhil students to enhance research collaborations in the field of AMR.
Up to 10 grants of £1000 each will be made to applicants for activities that support research advancement. Applications must be submitted by 10 March 2025.
Deadline
Submit this application to the AMR network by emailing amrnetwork@ineosoxford.ox.ac.uk by 10 March 2025. Applicants must also attach a letter of support from their academic supervisor.
If successful, the funds will be transferred to the applicant’s department.
Successful applicants will need to submit a brief report on how the funds were used and the impact on research by 10 December 2025.
We will be particularly supportive of applications that are interdisciplinary and applications that include match funding from another source, such as the KE Seed Fund and/or funding from your college/department or from a scientific society.
About
A grant will be awarded to provide funds to develop exciting investigator-initiated concepts focused on global health research, which will hopefully lead to successful longer term project funding from the NIH or equivalent funding sources. Examples of global health research include, but are not limited to telemedicine (e.g., remote planning of radiotherapy, or AI-supported automatic cancer prediction from screening data of cancers common in LMIC), development of low-cost technologies for diagnostics and treatment (e.g., auto-contouring of clinical targets applied to clinical trials in LMIC). Inclusion of existing global health research resources (e.g., AAPM GRSIC open source tools, or international clinical trial data).
Applications aligning with the American Association of Physicists in Medicine’s (AAPM) strategic priorities are especially encouraged, particularly in the following areas:
- Strategic Priority 1: Global health research in emerging medical physics fields such as radiopharmaceutical therapies and expanding beyond the usual radiology and radiation oncology.
- Strategic Priority 2: Global health research in computational physics integrating AI/ML/DT technologies.
Eligibility
Must be a member of American Association of Physicists in Medicine (AAPM) at the time of application (any membership category). Pending membership status not eligible. 10 years or less since receipt of a terminal research degree or medical physics residency, whichever is later. (Excludes those who have reached Associate Professor level; includes Postdoctoral Fellows with mentors and Research Scientists with mentors.)
Amount
USD$25,000
Apply to the Global Health Research Seed Funding Grant
About
Funding to develop and test novel therapeutics, medical devices, diagnostics You can apply for academically-led translational projects that aim to either:
- improve prevention, diagnosis, prognosis or treatment of significant health needs
- develop research tools that increase the efficiency of developing interventions.
All diseases and interventions are eligible for support. You can also address global health issues. Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a). You can submit follow-on proposals where you can justify the need for continued support. This is an ongoing funding opportunity. Application rounds close every March, July and November.
Amount
No limits
About
The 2025 calls will support a range of research and innovation actions (RIA) aimed at developing novel vaccines and therapeutics for tuberculosis, malaria and neglected tropical diseases. Additionally, coordination and support actions (CSA) strengthening the enabling environment for conducting clinical research in Africa will be funded at the individual level through fellowships in public health with emphasis on the areas of biostatistics, epidemiology, and modelling, as well as at the institutional level through regional networks of excellence for preparedness and response to outbreaks. Four calls for proposals will be launched:
1) HORIZON-JU-GH-EDCTP3-2025-01-two-stage covering 3 topics for Research and Innovation Actions (RIA):
- HORIZON-JU-GH-EDCTP3-2025-01-TB-01-two-stage: Global collaboration action for the development of vaccines for reducing the disease burden of Tuberculosis in sub-Saharan Africa;
- HORIZON-JU-GH-EDCTP3-2025-01-MALARIA-02-two-stage: Global collaboration action for research on existing Malaria therapeutics and clinical development of new antimalarial candidates;
- HORIZON-JU-GH-EDCTP3-2025-01-NTD-03-two-stage: Accelerating the development of prophylactic vaccines against Neglected Tropical Diseases (NTDs) in sub-Saharan Africa.
2) HORIZON-JU-GH-EDCTP3-2025-02-two-stage covering 1 topic for Coordination and Support Actions (CSA):
- HORIZON-JU-GH-EDCTP3-2025-02-FELLOWSHIP-01-two-stage: Global Health EDCTP3 and contributing partners funded Strategic Training Hubs for Fellowships in Public Health covering Biostatistics, Epidemiology and Modelling.
3) HORIZON-JU-GH-EDCTP3-2025-03-two-stage covering 1 topic for Coordination and Support Actions (CSA):
- HORIZON-JU-GH-EDCTP3-2025-03-NETWORKS-01-two-stage: Global collaborative action for strengthening the Regional Networks of Excellence and Epidemic Preparedness Consortia.
4) HORIZON-JU-GH-EDCTP3-2025-04-two-stage covering 2 topics Research and Innovation Actions (RIA):
- HORIZON-JU-GH-EDCTP3-2025-04-CH-01-two-stage: Global collaborative action tackling diarrhoeal diseases in the context of climate and health;
- HORIZON-JU-GH-EDCTP3-2025-04-ACCESS-02-two-stage: Transformative Innovations in global health.
Amount
The total budget is €214 million. Expected JU contribution per project are worth between €1.34m and €15.3m.
Eligibility
Country of applicant institution: Albania; Armenia; Benin; Bosnia and Herzegovina; Burkina Faso; Cameroon; Congo, Republic of the; Congo, the Democratic Republic of the; Côte d'Ivoire; Eswatini (formerly Swaziland); Ethiopia; European Union (EU); Faroe Islands; Gabon; Gambia, The; Georgia; Ghana; Guinea; Guinea-Bissau; Iceland; Israel; Kenya; Kosovo; Liberia; Malawi; Mali; Moldova, Republic of; Montenegro; Morocco; Mozambique; Namibia; Niger; Nigeria; North Macedonia; Norway; Rwanda; Senegal; Serbia; Sierra Leone; Somalia; South Africa; Tanzania, United Republic of; Tunisia; Turkey; Uganda; Ukraine; United Kingdom; Zambia; Zimbabwe.
Deadline
The calls for proposals are open. Interested consortia are invited to submit a short proposal by 20 March 2025 (first stage). Successful consortia will then be invited to submit a full proposal by September 2025 (second stage).
About
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.
This NOFO provides support for up to two years (R21 phase) for technology development and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds. All applicants must address both the R21 and R33 phases.
Amount
Maximum award USD $800,000
Apply to the NIH: Mobile Health: Technology and Outcomes in Low and Middle Income Countries
ABOUT
This annual grant offers early career researchers and global health professionals based anywhere in the world the opportunity to apply for funding in a topic related to tropical medicine and global health. In 2024 the RSTMH funded more than 220 Early Career Grants, their highest number yet.*** This opportunity will be available soon. The next call is expected to open in January 2025. This information is subject to change. ***
AMOUNT
Up to £5,000 over 1 year (including VAT).
ELIGIBILITY
Early career researchers and global health professionals based anywhere in the world, who have not had research funding in their own name before.
Apply to the Royal Society of Tropical Medicine and Hygiene: Early Career Grants Programme
About
This call supports implementation research addressing strategies for strengthening of health systems to improve equity in high quality care and health outcomes and reduce the prevalence and impact of chronic non-communicable diseases (NCDs) in low- and middle-income countries and/or in underserved populations experiencing health disparities such as Indigenous populations, in high-income countries.
Applicants to the 2025 funding call are invited to propose appropriately designed and targeted implementation research to support health system transformation and/or strengthening using evidence-based interventions that can be adapted to, and implemented in, LMICs and populations experiencing health disparities to encourage equitable health outcomes and decrease the burden of NCDs.
Process
GACD uses a a two-step application process. Applicants will need to submit a brief first stage proposal, which will be peer reviewed. All applicants will be provided with feedback from the first stage review process and successful applicants will be invited to submit a second stage proposal.
Webinar for prospective applicants: GACD will hold a webinar for prospective applicants in March 2025.
Key dates
Application Portal opens: 4 February 2025
Participating funding agencies confirmed: 28 March 2025
First stage proposal deadline: 16 June 2025 (18:00 CET)
First Stage proposal outcomes: 10 September 2025
Second stage proposal deadline: 22 October 2025 (18:00 CET)
Awards: January-April 2026
More info on the GACD Strengthening Health Systems opportunity
ABOUT
The NIHR Global Health Research (GHR) Health Policy and Systems (HPS) programmes will be looking for applications to this annual funding opportunity. GHR-HPS funds research to improve the understanding and effectiveness of health systems and health policy in low and middle income countries (LMICs) on the Development Assistance Committee (DAC) list. Research must address evidence needs relating to health systems that are locally identified and prioritised, and must promote health equity, aligning with the aims of Sustainable Development Goal 3. Applications can span from broad, ambitious programmes of research to projects with a narrower scope.
All applications must make clear:
- what will change as a result of the research, and how the change will be enacted
- what health service, system or policy area will be influenced and how it will be done
The GHR-HPS programmes replace the previously run Global Health Policy and Systems Research (HPSR) Programme and now commissions research through 3 programme bands.
This is a 2 stage (outline application then full application) researcher-led opportunity.
Webinar
In anticipation of this new HPS funding opportunity, a series of webinars to build capacity in the field of HPSR will be delivered by the Alliance for Health Policy and Systems Research at WHO, in partnership with NIHR. These will cover key HPSR theories, frameworks and research designs and the broader systems perspectives to consider when undertaking HPSR, as well as innovative methodological approaches and frontier topics. The first webinar will be held via Zoom at 11am (UK time) on 20 January 2025 – register to attend the Building capacity in HPSR webinar – Alliance for HPSR at WHO, in partnership with NIHR.
NIHR will then be running a dedicated webinar to support you with your application to GHR-HPS bands 1 to 3 in March 2025 – date to be confirmed. Further details and sign up information will be added to the funders webpage.
Eligibility
There are 3 bands of funding based on the scale and ambition of the proposed research, the maturity of partnerships, teams’ experience and expected capacity strengthening plans. Researchers from high income countries are not eligible to apply as Sole Lead. See Leadership model on funders webpage for more details.
NIHR will consider applications in any field of applied global health policy and systems research. This includes applications from experienced health systems and health policy researchers, or those who are new to research. All applications must benefit people living in one or more Official Development Assistance (ODA)-eligible country.
Amount
Through this opportunity, funding ranges from £0.25 to £4 million, over a period up to 5 years, depending on the band applied for.
ABOUT
The Medical Research Future Fund (MRFF) Australia, the National Health and Medical Research Council (NHMRC) Australia and National Institute for Health and Care Research (NIHR) UK are inviting applications for ambitious platform studies in areas of unmet medical need. The platform must be internationally collaborative, with joint leads based in Australia and the United Kingdom.
Applications to this funding opportunity must describe a platform trial seeking to evaluate a number of specified technologies. Each technology must have sufficient clinical, human proof of concept to justify a definitive efficacy study. This call is for either Phase 2 or Phase 3 focused platforms, where there is a pipeline of technologies which justifies a platform approach. This call will not support funding for studies aiming to run platforms seamlessly from phase 2 into phase 3. See call specifications for more details.
The funder is holding a webinar (1.5hrs) to support applicants to this funding opportunity on 19 November 2024, 08:00 UK (UTC+0)/19:00 AEDT (UTC+11). To register for the webinar, please sign up via their online form.
Amount: Aiming to fund 1 to 3 platforms for up to 7 Years. NHMRC and MRFF will fund the Australian research component and the NIHR will fund the UK research component of successful applications.
Learn more about the NIHR: Australia-UK platform studies in areas of unmet clinical need